Similarly, Bekeschus et al. tested different NIPP device setups and found that He/O2-generated NIPP significantly reduced tumor burden in the B16F10 melanoma mouse model, where elevated intratumor levels of CD8+ T cells and DCs were observed, too. The gene discussed is CD8A; the disease is neoplasm.